ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0RIS Circio Holding Asa

15.98
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Circio Holding Asa LSE:0RIS London Ordinary Share NO0013033795 CIRCIO HOLDING ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.98 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 10M -432.9M -2.2969 -6.96 3.01B

Agenda for Targovax Capital Markets Day 15 October 2018, in Oslo, Norway

12/10/2018 6:26am

PR Newswire (US)


Circio Holding Asa (LSE:0RIS)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Circio Holding Asa Charts.

OSLO, Norway, Oct. 12, 2018 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, will host a Capital Markets Day in Oslo on Monday 15 October 2018, from 08:3010:15 

The event will include a presentation by a world leading expert on pancreatic cancer, Professor Daniel Palmer, who is the Chair of Medical Oncology at the University of Liverpool and Clatterbridge Cancer Centre. Professor Palmer has been involved in a number of large international clinical studies in pancreatic cancer and was the Principal Investigator of Targovax's TG01 phase I/II trial in resected pancreatic cancer, in combination with adjuvant gemcitabine. Top-line survival data from the trial were released in May 2018 (see press release here) and at the upcoming event Professor Palmer will present the full study results.

Event venue: Hotel Continental, Oslo, Norway

Date: 15 October, 2018

Time: 08:30 – 10:15 CET

Agenda:

08:15 – 08:30: Registration and breakfast

08:30 – 08:40: Welcome remarks, Øystein Soug, CEO, Targovax

08:40 – 09:20: Resected pancreatic cancer: overview and TG01 full data, Prof. Daniel Palmer

09:20 – 09:40: Update on TG strategy, Øystein Soug, CEO, Targovax

09:40 – 09:50: ONCOS overview, Dr. Erik Digman Wiklund, CBO, Targovax

09:50 – 10:10: ONCOS-102 interim data in melanoma and mesothelioma, Dr. Magnus Jäderberg, CMO, Targovax

10:10 – 10:20: Financial and closing remarks, Dr. Torbjørn Furuseth, CFO, Targovax

A live webcast of the symposium will be available in the Events and Presentations section of the Targovax website.

To register for the event, please contact renate.birkeli@targovax.com.  

For further information, please contact:

Renate Birkeli, Investor Relations
Phone: +47-922-61-624
Email: renate.birkeli@targovax.com

Media and IR enquires:

Andreas Tinglum - Corporate Communications (Norway)
Phone: +47-9300-1773
Email: andreas.tinglum@corpcom.no

Simon Conway/Stephanie Cuthbert - FTI Consulting (International)
Phone: +44-20-3727-1000
Email: Targovax@fticonsulting.com

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/targovax/r/agenda-for-targovax-capital-markets-day-15-october-2018--in-oslo--norway,c2642877

Cision View original content:http://www.prnewswire.com/news-releases/agenda-for-targovax-capital-markets-day-15-october-2018-in-oslo-norway-300730075.html

SOURCE Targovax

Copyright 2018 PR Newswire

1 Year Circio Holding Asa Chart

1 Year Circio Holding Asa Chart

1 Month Circio Holding Asa Chart

1 Month Circio Holding Asa Chart

Your Recent History

Delayed Upgrade Clock